Monsanto Views Bayer’s Current Proposal as Incomplete and Financially Inadequate; Company Open to Discussing Potential Path Forward That Would Create Appropriate Value for Monsanto Shareowners

Go back to Monsanto Views Bayer’s Current Proposal as Incomplete and Financially Inadequate; Company Open to Discussing Potential Path Forward That Would Create Appropriate Value for Monsanto Shareowners

Monsanto (MON) said to expect a Bayer counteroffer - FBN's Gasparino

May 25, 2016 12:24 PM EDT

Monsanto (NYSE: MON) is said to expect a Bayer counteroffer. according to Fox Business Network's Charlie Gasparino. The following was posted to Twitter on Wednesday:

#BreakingNews @MonsantoCo expect @Bayer counter offer we lay out the odds NOW @FoxBusiness @TeamCavuto $MON

— Charles Gasparino (@CGasparino) May 25, 2016
... More

Jefferies Upgrades Monsanto (MON) to Buy

May 25, 2016 6:40 AM EDT

Jefferies upgraded Monsanto (NYSE: MON) from Hold to Buy with a price target of $132.00 (from $95.00).

Analyst Laurence Alexander commented, "Fundamentals starting to scrabble out of a trough, a determined suitor, increasing pressure on management to be proactive, and significant optionality suggest a favorable... More

Monsanto (MON) Resumes Trading After Rejecting Bayer Offer

May 24, 2016 1:07 PM EDT

Monsanto (NYSE: MON) resumes trading after rejecting Bayer's offer. Shares are up 2.4% to $108.50. Investors are focused on comments that the company is "open to continued and constructive conversations"

... More